Key Points
Mankind Pharma, the country's fourth largest pharma company, has countered the objections raised by a retail chemists' body which had sought withdrawal of advertisement of its vitamin supplement, HealthOK..
According to the All India Organisation of Chemists and Druggists (AIOCD), the advertisement that features actor Ranveer Singh insinuates that non-vegetarian individuals are healthier...
In a letter dated February 13 to the association, the company said its intent was not to hurt anyone or undervalue the benefits of vegetarian food...
A majority of the Indian population is deficient in Vitamin D and Vitamin B12, with ample evidence being seen specifically in women and the elderly population, it said, adding: "Mankind Pharma is only suggesting an utterly vegetarian food supplement for vegetarian Indian citizens to take good care of their health."..
The HealthOK multivitamin tablets can fulfil nutritional deficiencies and provide an added benefit of staying energetic due to the presence of antifatigue taurine and ginseng in the product, it claimed.. (You can now subscribe to our Economic Times WhatsApp channel).
You might be interested in
Chemists' body asks Mankind to drop health supplement ad featuring Ranveer Singh
12, Feb, 24The content implies that vegetarian individuals are at risk of vitamin deficiency, suggesting that your product can prevent this, the AIOCD has said in its letter to Rajiv Juneja, managing director of Mankind Pharma, the makers of HealthOk.
India's retail chemists ask BJP to include the banning of e-pharmacies in its manifesto
30, Mar, 24AIOCD said that the online medicine business poses a serious threat to public health, serving as a gateway for counterfeit medications in the country. We've provided a detailed memorandum outlining these concerns. Allowing it to continue could lead to the monopolisation by big corporations and chains. In the interest of public health and to protect the younger generation from drug abuse, the Government of India should ban E-Pharmacies nationwide, the letter said.
Mankind Pharma IPO opens for subscription today: Should you bid?
25, Apr, 23The issue opens for subscription today and will be available for the public to bid till April 27. Investors can bid for 13 shares in one lot and in multiples thereof. The price band is set at Rs 1,026-1,080 per share.